Tatiana Ort

Company: AstraZeneca

Job title: Head of Bioscience, Immunology

Seminars:

Treg Cell Therapy in Autoimmunity: Perspective on Target Patient Populations & Clinical Strategy 1:30 pm

Developing "armed" Tregs as a promising therapeutic option to induce immune tolerance Understanding considerations for diseases and target patient populations Giving an overview of the clinical development strategy Read more

day: Conference Day Two